Hayat Pharmaceutical Industries Co (AMM:HPIC) 3-Month Share Buyback Ratio : 0.00% (As of Mar. 2025 )

View and export this data going back to 2006. Start your Free Trial

What is Hayat Pharmaceutical Industries Co 3-Month Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Hayat Pharmaceutical Industries Co's current 3-Month Share Buyback Ratio was 0.00%.

Competitive Comparison of Hayat Pharmaceutical Industries Co's 3-Month Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's 3-Month Share Buyback Ratio, along with its competitors' market caps and 3-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hayat Pharmaceutical Industries Co's 3-Month Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's 3-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Hayat Pharmaceutical Industries Co's 3-Month Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Hayat Pharmaceutical Industries Co 3-Month Share Buyback Ratio Calculation

Hayat Pharmaceutical Industries Co's 3-Month Share Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

3-Month Share Buyback Ratio	=	(Shares Outstanding (EOP) (Dec. 2024 )	-	Shares Outstanding (EOP) (Mar. 2025 ))	/	Shares Outstanding (EOP) (Dec. 2024 )
	=	(9.500	-	9.500)	/	9.500
	=	0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hayat Pharmaceutical Industries Co (AMM:HPIC) 3-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Hayat Pharmaceutical Industries Co 3-Month Share Buyback Ratio Related Terms

Hayat Pharmaceutical Industries Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hayat Pharmaceutical Industries Co (AMM:HPIC) » Definitions » 3-Month Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Nile St. Al-Rajeeb, P.O. Box 1564, Amman, JOR, 11118

Website

https://www.hayatpharma.com

Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. Its principal activity is producing human and veterinary in all its forms and medical stickers and stockings. The company is also involved in the production of medical supplies, body care lotions, cosmetics, and initiating marketing campaigns as well as import and export operations. It has developed and registered a hundred sixteen different dosage forms/pack sizes in the Jordan market representing fifty six different brands (molecules) in various therapeutic areas. Its products include Cardiovascular system, Infectious disease Dermatology, Gastrointestinal system, and Respiratory system.

Hayat Pharmaceutical Industries Co Headlines

No Headlines